Evidence of robust memory T‐cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2).

Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Keywords: COVID-19; immunity; T cell; myeloproliferative neoplasm; CML EN COVID-19 immunity T cell myeloproliferative neoplasm CML 692 696 5 05/17/21 20210515 NES 210515 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel coronavirus, has led to very significant global healthcare challenges. Patients with chronic MPN without detectable antibodies had a T-cell response that was broadly equivalent in many areas to that seen in those with detectable anti-SARS-CoV-2 antibodies. For the first time, we have demonstrated that patients with chronic MPN can mount functional memory T-cell responses following natural SARS-CoV-2 exposure. [Extracted from the article]